Research Article

NRF2 Regulates HER1 Signaling Pathway to Modulate the Sensitivity of Ovarian Cancer Cells to Lapatinib and Erlotinib

Table 1

Antibodies used in the study.

Catalogue
AntibodyHostNumberCompany

HER1-EP38YRabbitab52894Abcam
pHER1Rabbitab40815Abcam
NRF2Rabbitab89443Abcam
pNRF2-EP1809YRabbitab76026Abcam
pAkt-Ser473Rabbitab9271Cell signalling
HO-1Rabbit5853SCell signalling
HRP-linked anti-secondary antibodyRabbit7074Cell signalling
β-ActinRabbitab1801Abcam